IL88507A - 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them - Google Patents

2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them

Info

Publication number
IL88507A
IL88507A IL88507A IL8850788A IL88507A IL 88507 A IL88507 A IL 88507A IL 88507 A IL88507 A IL 88507A IL 8850788 A IL8850788 A IL 8850788A IL 88507 A IL88507 A IL 88507A
Authority
IL
Israel
Prior art keywords
hydrogen
4alkyl
different
same
preparation
Prior art date
Application number
IL88507A
Other languages
English (en)
Original Assignee
Smithkline Beckman Intercredit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878728336A external-priority patent/GB8728336D0/en
Priority claimed from GB888820184A external-priority patent/GB8820184D0/en
Application filed by Smithkline Beckman Intercredit filed Critical Smithkline Beckman Intercredit
Publication of IL88507A publication Critical patent/IL88507A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
IL88507A 1987-12-03 1988-11-27 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them IL88507A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878728336A GB8728336D0 (en) 1987-12-03 1987-12-03 Compounds
GB888820184A GB8820184D0 (en) 1988-08-25 1988-08-25 Compounds

Publications (1)

Publication Number Publication Date
IL88507A true IL88507A (en) 1993-02-21

Family

ID=26293140

Family Applications (1)

Application Number Title Priority Date Filing Date
IL88507A IL88507A (en) 1987-12-03 1988-11-27 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them

Country Status (16)

Country Link
EP (1) EP0322133B1 (pt)
JP (1) JPH02502462A (pt)
KR (1) KR900700465A (pt)
CN (1) CN1033380A (pt)
AT (1) ATE63742T1 (pt)
DE (1) DE3862928D1 (pt)
ES (1) ES2032024T3 (pt)
FI (1) FI893632A0 (pt)
GR (1) GR3002113T3 (pt)
HU (1) HU203325B (pt)
IL (1) IL88507A (pt)
NZ (1) NZ227125A (pt)
PH (1) PH25508A (pt)
PT (1) PT89110B (pt)
WO (1) WO1989005297A1 (pt)
ZW (1) ZW16588A1 (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89029A (en) * 1988-01-29 1993-01-31 Lilly Co Eli Fungicidal quinoline and cinnoline derivatives, compositions containing them, and fungicidal methods of using them
IL89027A (en) * 1988-01-29 1993-01-31 Lilly Co Eli Quinazoline derivatives, process for their preparation and fungicidal, insecticidal and miticidal compositions containing them
US5411963A (en) * 1988-01-29 1995-05-02 Dowelanco Quinazoline derivatives
US5114939A (en) * 1988-01-29 1992-05-19 Dowelanco Substituted quinolines and cinnolines as fungicides
GT198900008A (es) * 1988-01-29 1990-07-17 Derivados de quinolina, quinazolina y cinolina.
CA2011086A1 (en) * 1989-03-17 1990-09-17 Karl-Heinz Geiss 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom
IE63502B1 (en) * 1989-04-21 1995-05-03 Zeneca Ltd Aminopyrimidine derivatives useful for treating cardiovascular disorders
CA2015981A1 (en) * 1989-05-10 1990-11-10 Thomas H. Brown Compounds
GB9008818D0 (en) * 1990-04-19 1990-06-13 Ici Plc Amine derivatives
GB9012592D0 (en) * 1990-06-06 1990-07-25 Smithkline Beecham Intercredit Compounds
GB9022644D0 (en) * 1990-10-18 1990-11-28 Ici Plc Heterocyclic compounds
KR930702292A (ko) * 1990-11-06 1993-09-08 알렌 제이. 스피겔 종양 치료 활성을 증대시키기 위한 퀴나졸린 유도체
WO1992014716A1 (en) * 1991-02-20 1992-09-03 Pfizer Inc. 2,4-diaminoquinazolines derivatives for enhancing antitumor activity
JP2657760B2 (ja) * 1992-07-15 1997-09-24 小野薬品工業株式会社 ４−アミノキナゾリン誘導体およびそれを含有する医薬品
KR0144833B1 (ko) * 1992-12-28 1998-07-15 김태훈 신규의 퀴나졸린 유도체 및 그의 제조방법
WO1995007267A1 (fr) * 1993-09-10 1995-03-16 Eisai Co., Ltd. Compose de quinazoline
TW334434B (en) * 1995-05-16 1998-06-21 Kanebo Ltd Novel quinazoline compound and anti-tumor agent
WO1997042192A1 (de) * 1996-05-07 1997-11-13 Basf Aktiengesellschaft Imidazo-chinazoline, sie enthaltende mittel und deren verwendung zur bekämpfung von schadpilzen und tierischen schädlingen
IN188411B (pt) * 1997-03-27 2002-09-21 Yuhan Corp
GB9708917D0 (en) 1997-05-01 1997-06-25 Pfizer Ltd Compounds useful in therapy
GB9711650D0 (en) * 1997-06-05 1997-07-30 Pfizer Ltd Compounds useful in therapy
WO1999050264A1 (fr) * 1998-03-30 1999-10-07 Kyowa Hakko Kogyo Co., Ltd. Derives de quinazoline
AU2002361846A1 (en) * 2001-12-21 2003-07-15 Bayer Pharmaceuticals Corporation Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
RS63204A (en) 2002-01-17 2006-10-27 Neurogen Corporation Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
US7618975B2 (en) * 2003-07-03 2009-11-17 Myriad Pharmaceuticals, Inc. 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
US7329664B2 (en) 2003-07-16 2008-02-12 Neurogen Corporation Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analogues
CA2592900A1 (en) * 2005-01-03 2006-07-13 Myriad Genetics Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
JP2008526776A (ja) * 2005-01-03 2008-07-24 ミリアド ジェネティクス， インコーポレイテッド 脳癌の治療の方法
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
US8252806B2 (en) 2005-03-14 2012-08-28 Neurosearch A/S Potassium channel modulating agents and their medical use
WO2006105056A2 (en) * 2005-03-28 2006-10-05 Fmc Corporation Insecticidal 2,4-diaminoquinazolines and related derivatives
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
CA2658804A1 (en) 2006-07-25 2008-01-31 Vecta Ltd. Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with ppi
CN101784276A (zh) * 2007-06-27 2010-07-21 传染性疾病研究院 化合物在用于制备抗结核药剂中的用途
SI3321265T1 (sl) 2015-03-04 2020-07-31 Gilead Sciences, Inc. Spojine 4,6-diamino-pirido(3,2-d)pirimidina in njihova uporaba kot modulatorji toličnih receptorjev
US10640499B2 (en) 2016-09-02 2020-05-05 Gilead Sciences, Inc. Toll like receptor modulator compounds
MA46093A (fr) 2016-09-02 2021-05-19 Gilead Sciences Inc Composés modulateurs du recepteur de type toll
CN106518849B (zh) * 2016-10-27 2019-08-16 上海人类基因组研究中心 喹唑啉类化合物及其制备方法和用途
TWI751516B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202212339A (zh) 2019-04-17 2022-04-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202115056A (zh) 2019-06-28 2021-04-16 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法
AU2022341967A1 (en) * 2021-09-07 2024-05-16 Gismo Therapeutics, Inc. Compounds and pharmaceutical compositions comprising inhibitors of amyloid peptide interactions with glycosaminoglycans, methods of treatment, and use thereof
WO2024101336A1 (ja) * 2022-11-07 2024-05-16 国立大学法人京都大学 含窒素複素環化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE958197C (de) * 1952-04-18 1957-02-14 Dr Siegfried Skraup Verfahren zur Herstellung von 2, 4-Diaminochinazolin
GB806772A (en) * 1956-03-29 1958-12-31 Wellcome Found Diaminoquinazolines and method of preparing
CH457460A (fr) * 1966-06-20 1968-06-15 Parke Davis & Co Procédé de préparation de quinazolines
US3635979A (en) * 1969-09-29 1972-01-18 Pfizer Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines
GB1390014A (en) * 1971-05-07 1975-04-09 Koninklijke Pharma Fab Nv Process for the preparation of carbocyclic fused pyrimidine derivatives
US3956495A (en) * 1973-10-30 1976-05-11 Eli Lilly And Company 2,4-Diaminoquinazolines as antithrombotic agents
US4098788A (en) * 1977-06-20 1978-07-04 Bristol-Myers Company Process for preparing quinazolines
US4287341A (en) * 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones

Also Published As

Publication number Publication date
DE3862928D1 (de) 1991-06-27
NZ227125A (en) 1990-09-26
ATE63742T1 (de) 1991-06-15
PH25508A (en) 1991-07-24
JPH02502462A (ja) 1990-08-09
ES2032024T3 (es) 1993-01-01
KR900700465A (ko) 1990-08-13
HUT50322A (en) 1990-01-29
EP0322133A1 (en) 1989-06-28
EP0322133B1 (en) 1991-05-22
PT89110B (pt) 1993-03-31
ZW16588A1 (en) 1989-06-21
HU203325B (en) 1991-07-29
PT89110A (pt) 1988-12-01
GR3002113T3 (en) 1992-12-30
WO1989005297A1 (en) 1989-06-15
CN1033380A (zh) 1989-06-14
FI893632A0 (fi) 1989-07-31

Similar Documents

Publication Publication Date Title
IL88507A (en) 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them
EG18408A (en) Process for preparing novel substituted quinoline derivatives
HUT40401A (en) Process for preparing derivatives of tyronine and pharmaceutical compositions containing thereof
GB8804443D0 (en) Compounds
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
GR871549B (en) Amino acid derivative anticonvulsant
ES557149A0 (es) Un procedimiento para la preparacion de derivados peptidicos de histidinilprolinamida.
IL78780A (en) 1,3-oxathiane-4-phenyl-5-alkenyl derivatives,their preparation and pharmaceutical compositions containing them
SE8305362D0 (sv) Novel substituted phenylazacycloalkanes, processes for preparation and pharmaceutical preparations for such compounds
EP0220654A3 (en) Gonadoliberine analogues, process for preparing them, pharmaceutical composition and use